Jill Buck
Chief Development Officer · enGene Therapeutics Inc.
Individual
- 2025
- Feb 3, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jill Buck files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William Grossman - $10K in ENGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jill Buck?
Jill Buck is a corporate insider, tracked as Chief Development Officer of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jill Buck last file a Form 4?
The most recent primary Form 4 on record is dated 3 February 2026, one of 2 filings going back to 2025.